Aperio Group’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Aperio Group’s Portfolio SCLN Stock Details SCLN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell
2017 Q3	$486K	Buy
2017 Q2	$317K	Buy
2017 Q1	$233K	Buy
2016 Q4	$132K	Sell
2016 Q3	$135K	Buy
2016 Q2	$150K	Buy
2016 Q1	$114K	Buy